DexCom
DXCM
291 hedge funds and large institutions have $7.84B invested in DexCom in 2016 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 95 increasing their positions, 108 reducing their positions, and 36 closing their positions.
39% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 36
18% more capital invested
Capital invested by funds: $6.66B → $7.84B (+$1.18B)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
4% more funds holding
Funds holding: 279 → 291 (+12)
12% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 108
96% less call options, than puts
Call options by funds: $23M | Put options by funds: $579M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$499M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$326M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$100M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$72.5M |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$42.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$71.6M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$71.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$65.5M |
| 4 |
Jennison Associates
New York
|
-$45.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$43.7M |
DXCM Hedge Fund Activity: Q3 2016 in Review
291 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2016, worth a combined $7.84B — up 18% from $6.66B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new DXCM positions and 36 closed out — a net gain of 14 holders — while 95 added to existing stakes and 108 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $499M. The largest seller was Wells Fargo, cutting an estimated $71.6M.
- 291 institutional investors held DexCom (DXCM) as of Q3 2016, up from 279 in Q2 2016.
- Funds reported $7.84B of DexCom stock for Q3 2016, up 18% quarter-over-quarter.
- 50 funds opened new DexCom positions in Q3 2016 and 36 closed out, a net change of +14 holders.
- The largest DexCom buyer in Q3 2016 was Baillie Gifford & Co, an estimated $499M added.
- The largest DexCom seller in Q3 2016 was Wells Fargo, an estimated $71.6M sold.
Based on aggregated 13F filings for Q3 2016.